Gotu Kola (Centella asiatica): What the Evidence Actually Shows

Gotu kola (Centella asiatica) is one of the most heavily marketed botanicals in the modern longevity and nootropic space, promoted for everything from memory to anti-aging skin. Yet the herb’s actual human evidence is uneven: it is genuinely useful for one vascular indication, plausible for topical wound care, and largely speculative for the “brain” claims that drive its supplement sales. This monograph grades each use against primary sources.

What gotu kola is

Centella asiatica is a small creeping herb native to wetlands across Asia, used for centuries in Ayurvedic and traditional Chinese and Indonesian medicine. Its activity is attributed to a family of pentacyclic triterpenes—principally asiaticoside, madecassoside, and their aglycones asiatic acid and madecassic acid. A standardized extract called the total triterpenic fraction of Centella asiatica (TTFCA, also sold as titrated extract) is the form used in most of the better clinical work, which matters because raw-herb teas and unstandardized capsules deliver very different and often unknown triterpene doses.^[1]

Where the human evidence is strongest: chronic venous insufficiency

The best-supported use of gotu kola is chronic venous insufficiency (CVI)—the leg swelling, heaviness, and microcirculatory leakage caused by failing vein valves. Randomized, placebo-controlled trials of TTFCA in CVI and diabetic microangiopathy reported reductions in ankle edema, capillary filtration, and subjective heaviness over weeks of oral dosing.^[2]A related randomized placebo-controlled trial even found that TTFCA modified the echogenicity (stability) of femoral arterial plaques, consistent with an effect on the connective-tissue matrix of the vessel wall.^[3] The mechanistic story is coherent: gotu kola triterpenes modulate collagen and the extracellular matrix, which is exactly the tissue that fails in venous disease. The caveat is that much of this trial program came from a small number of overlapping investigator groups, so independent replication remains thinner than the enthusiasm suggests. Still, for CVI this is real, graded human evidence—not mechanism alone.

Wound healing and scarring: plausible, mostly topical

Gotu kola’s second-best-supported use is wound healing, and here the rationale rests on well-characterized biology. Asiaticoside and madecassoside stimulate fibroblast collagen synthesis and angiogenesis, the core processes of granulation and re-epithelialization; pharmacological reviews summarize a consistent pro-healing signal across preparations.^[4]At the cellular level, the same triterpenes can also restrain excessive fibrosis: in cultured keloid fibroblasts, asiaticoside suppressed invasive growth through the GDF-9/MAPK/Smad pathway, hinting at a dual role in both healing and scar control.^[5] Grade this as mechanistically strong with supportive but modest clinical data, concentrated in topical formulations. It is a reasonable adjunct for wound and scar care; it is not a substitute for standard wound management.

Cognition and mood: small, mixed, underpowered

The claims that sell gotu kola as a nootropic are the weakest. A frequently cited double-blind, placebo-controlled trial in healthy elderly volunteers reported improvements in working memory and self-rated mood at a high dose of Centella asiatica extract—but the sample was small, the effects were modest, and the design was single-study rather than a replicated program.^[6] That is a hypothesis-generating result, not an established effect. Much of the supporting “neuroprotection” literature is preclinical, so the cognitive case currently rests on one small human trial plus animal and in-vitro work—a thin foundation for the confident memory and focus marketing seen online.

Anxiety: a single intriguing acute study

For anxiety, the human data amount to essentially one well-controlled experiment. In a double-blind, placebo-controlled study, a single oral dose of gotu kola blunted the acoustic startle response in healthy subjects, a physiological proxy for anxiety reactivity.^[7]This is a clean, interpretable finding, but it measured an acute startle reflex in healthy volunteers—not clinical anxiety, not over time, and never replicated at scale. Treat it as a promising signal that has not been developed into evidence of therapeutic anti-anxiety effect.

The collagen and skin-aging mechanism

Much of gotu kola’s appeal in longevity and cosmetic contexts traces to its effect on collagen. Triterpene-driven stimulation of fibroblast collagen synthesis is the same mechanism that plausibly underlies both its venous and wound-healing effects, and pharmacokinetic and pharmacological reviews catalog measurable connective-tissue activity.^[4] But a molecular mechanism that raises collagen in a dish or a wound bed does not automatically translate into systemic anti-aging or oral skin-rejuvenation benefit. For internal “longevity” use, the human outcome data simply do not exist yet—this remains mechanism in search of trials.

Safety

Gotu kola is generally well tolerated, especially topically and at the doses used in venous trials. The notable concern is hepatotoxicity: Centella asiatica appears in reviews of herb-induced liver injury associated with traditional Indian (Ayush) remedies, with case reports of cholestatic and hepatocellular injury that typically resolved on withdrawal.^[8]These are rare but real signals, so anyone using gotu kola long-term—particularly with other supplements or existing liver disease—should monitor and stop at any sign of jaundice, dark urine, or right-upper-quadrant pain. As with any botanical, product quality and triterpene standardization vary widely, and pregnancy is a sensible reason to avoid it.

Verdict

Gotu kola’s strongest human evidence is for chronic venous insufficiency and, secondarily, topical wound and scar care, where standardized triterpene extracts show graded clinical and mechanistic support; the trendy cognitive, anxiety, and longevity claims rest on single small trials and mechanism rather than robust, replicated data. Use it for the vascular and wound indications with realistic expectations and an eye on liver safety—and treat the “brain” marketing as unproven.